Target intelligence / Profile preview

novel transcript, antisense PLVAP

Molecular classification
Other (non-coding RNA)
01

Overview

This entry represents a non-coding RNA gene designated as "novel transcript, antisense PLVAP" (Ensembl: ENSG00000269350), transcribed in the antisense orientation relative to the protein-coding PLVAP gene. There is no evidence that this RNA encodes a protein or functions as a typical therapeutic target such as a receptor, enzyme, channel, or transporter. No canonical abbreviation, aliases, or functional annotations are established. No involvement in drug response or disease has been reported. Its biological and clinical significance, if any, remains uncharacterized or unknown[1]. Additional context: - The canonical PLVAP gene (distinct from this transcript, Ensembl: ENSG00000130300) encodes an endothelial membrane protein essential for the formation of diaphragms in vascular endothelia and is implicated in vascular permeability, angiogenesis, and disease, which are unrelated to this antisense transcript[2][3][4][5][7]. - There is no evidence or listing in major databases that the antisense transcript is therapeutically targeted, serves as a biomarker, or is implicated in specific disease functions. No further structured information can be provided for this entry due to lack of characterization and evidence for its role as a bona fide therapeutic target[1].

02

Biological functions

Unknown
03

Disease associations

Unknown

Beyond the preview

Go deeper on novel transcript, antisense PLVAP.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on novel transcript, antisense PLVAP.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call